GGrantIndex
Sort

85,873 grants matching alzheimers

Yale Alzheimer Disease Research Center

$3,170,528
Stephen M Strittmatter · Yale University · P30 · FY2024 · AG

Diabetes and brain amyloid in middle aged Hispanics

$3,169,894
Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2022 · AG

Center for Alzheimer's and Related Dementias: Detection of cryptic exons (splicing differences) in TDP-43 as biomarkers for frontotemporal dementia and Alzheimer's disease

$3,169,680
Andrew Singleton · National Institute On Aging · ZIA · FY2024 · AG

Cerebral amyloid angiopathy, metabolic dysregulation, and the neurovascular unit - Resubmission - 1

$3,164,945
Jorge A Ghiso · New York University School Of Medicine · RF1 · FY2020 · AG

The Four Repeat Tauopathy Neuroimaging Initiative

$3,164,662
Adam L Boxer · University Of California, San Francisco · R01 · FY2017 · AG

Clinical Evaluation of PET Radiotracers

$3,163,585
Robert Innis · National Institute Of Mental Health · ZIA · FY2014 · MH

Dysfunction of the Autophagy-Lysosomal Pathway as a Common Mechanism of Neurodegeneration

$3,162,400
Steven M Finkbeiner · J. David Gladstone Institutes · RF1 · FY2017 · AG

Dominantly Inherited Alzheimer Network

$3,159,894
John Morris · Washington University · U19 · FY2012 · AG

New Approaches to Dementia Heterogeneity

$3,158,487
Bruce L Miller · University Of California, San Francisco · P30 · FY2019 · AG

New Approaches to Dementia Heterogeneity

$3,158,395
Bruce L Miller · University Of California, San Francisco · P30 · FY2020 · AG

A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects

$3,156,733
Steven Lee Wagner · University Of California, San Diego · R01 · FY2021 · AG

BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study

$3,155,165
E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2024 · AG

The Four Repeat Tauopathy Neuroimaging Initiative

$3,154,975
Adam L Boxer · University Of California, San Francisco · R01 · FY2019 · AG

NORTHWESTERN Alzheimer's Disease Research Center

$3,154,561
Robert J Vassar · Northwestern University At Chicago · P30 · FY2025 · AG

Johns Hopkins Alzheimer's Disease Research Center

$3,154,067
Marilyn S Albert · Johns Hopkins University · P30 · FY2020 · AG

Penn Alzheimer's Disease Research Center (ADRC)

$3,152,120
David A Wolk · University Of Pennsylvania · P30 · FY2021 · AG

Causes and Consequences of Healthcare Inefficiency in Alzheimer’s Disease and Related Dementias

$3,149,542
Amber E Barnato · Dartmouth College · P01 · FY2025 · AG

Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease

$3,148,529
John M. Sedivy · Brown University · P01 · FY2025 · AG

Alzheimer's Disease Research Center

$3,148,108
Scott A Small · Columbia University Health Sciences · P30 · FY2021 · AG

UCSD Alzheimer's Disease Research Centers P30

$3,147,902
James B Brewer · University Of California, San Diego · P30 · FY2019 · AG

Decoding the role of diverse astrocyte populations in aging and AD

$3,145,948
Hui Zheng · Baylor College Of Medicine · RF1 · FY2016 · AG

Functional And Multi-Omics Approaches To Elucidate The Regulation Of Proteasome Complex In Neurodegenerative Diseases

$3,145,300
Natura Myeku · Columbia University Health Sciences · RF1 · FY2025 · NS

Developing an Optogenetics Technology Based on Natural Potassium-selective Channelrhodopsins

$3,145,118
John L Spudich · University Of Texas Hlth Sci Ctr Houston · RF1 · FY2023 · NS

Next Generation Translational Proteomics for Alzheimer's and Related Dementias

$3,144,564
Michael J Maccoss · University Of Washington · U19 · FY2021 · AG

Next Generation Translational Proteomics for Alzheimer's and Related Dementias

$3,144,562
Michael J Maccoss · University Of Washington · U19 · FY2022 · AG